Annex D. i+solutions model Long-Term Agreement (LTA) DLM ITB-Iplus/GDF-MED/2024/1

Annex C. List of priority countries for TB medicines registration DLM ITB-Iplus/GDF-MED/2024/1

Annex B. List and technical specifications of products requested DLM ITB-Iplus/GDF-MED/2024/1

Annex A. Financial Bid Response Form DLM ITB-Iplus/GDF-MED/2024/1

ITB document DLM ITB-Iplus/GDF-MED/2024/1

June 2024 - Supply delays for some products related to general laboratory supplies - Technologie Transfer Marburg e.V. (TTM)_updated May 2025

2024 TPMAT Recommendations to WHO PQ EOI 22nd Edition

June 2024 - Urgent Field Safety Note concerning of the GXMTB/RIF-ULTRA-50 Kit B/N 1000714555- Lot 39116, manufactured by Cepheid

2024.05.31 Rifampicin Delays

Is convenience really king? Comparative evaluation of catastrophic costs due to tuberculosis in the public and private healthcare sectors of Viet Nam: a longitudinal patient cost study

Hoa Binh Nguyen, Luan Nguyen Quang Vo, Rachel Jeanette Forse, Anja Maria Christine Wiemers, Huy Ba Huynh, Thuy Thi Thu Dong, Yen Thi Hoang Phan, Jacob Creswell, Thi Minh Ha Dang, Lan Huu Nguyen, Jad Shedrawy, Knut Lönnroth, Tuan Dinh Nguyen, Luong Van Dinh, Kristi Sidney Annerstedt & Andrew James Codlin